BCLI
BRAINSTORM CELL THERAPEUTICS INC.
-0.02 (-2.04%)0.96USD2.0K成交股數10.6M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 | 07-28 | FRENKEL JACOB A | Director | A 獲配股票 | 100K | – | – | 344K | SEC |
| 2026-02-26 | 05-29 | Yablonka Uri | EVP & Chief Business Officer | A 獲配股票 | 150K | – | – | 218K | SEC |
| 2026-02-26 | 05-29 | Lebovits Chaim | President & CEO | A 獲配股票 | 1.8M | – | – | 2.0M | SEC |
| 2026-02-26 | 05-29 | FRENKEL JACOB A | Director | A 獲配股票 | 200K | – | – | 244K | SEC |
| 2026-02-26 | 05-29 | Patlis Alla | See Remarks | A 獲配股票 | 100K | – | – | 144K | SEC |
| 2026-02-26 | 05-29 | ARBEL IRIT | Director | A 獲配股票 | 120K | – | – | 161K | SEC |
| 2025-01-01 | 01-07 | Dagher Ibrahim B. | Chief Medical Officer | A 獲配股票 | 50.0K | – | – | 66.8K | SEC |
| 2025-01-01 | 01-03 | Yablonka Uri | EVP & Chief Business Officer | A 獲配股票 | 40.0K | – | – | 48.5K | SEC |
| 2025-01-01 | 01-03 | Patlis Alla | See Remarks | A 獲配股票 | 40.0K | – | – | 44.3K | SEC |
| 2025-01-01 | 01-03 | Naor Nir | Director | A 獲配股票 | 30.7K | – | – | 31.5K | SEC |
| 2025-01-01 | 01-03 | Lindborg Stacy | Director | A 獲配股票 | 20.0K | – | – | 48.2K | SEC |
| 2025-01-01 | 01-03 | Lebovits Chaim | President & CEO | A 獲配股票 | 120K | – | – | 201K | SEC |
| 2025-01-01 | 01-03 | ARBEL IRIT | Director | A 獲配股票 | 30.7K | – | – | 41.1K | SEC |
| 2025-01-01 | 01-03 | Yablonka Uri | EVP & Chief Business Officer | A 獲配股票 | 20.0K | – | – | 68.5K | SEC |
| 2025-01-01 | 01-03 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A 獲配股票 | 50.0K | – | – | 52.0K | SEC |
| 2025-01-01 | 01-03 | Polverino Anthony J. | Director | A 獲配股票 | 24.0K | – | – | 25.7K | SEC |
| 2025-01-01 | 01-03 | FRENKEL JACOB A | Director | A 獲配股票 | 40.0K | – | – | 43.8K | SEC |
| 2025-01-01 | 01-03 | Bairu Menghisteab | Director | A 獲配股票 | 24.0K | – | – | 24.0K | SEC |
| 2024-10-01 | 10-02 | Lebovits Chaim | President & CEO | P 公開市場買進 | 1.8K | 3.43 | 6K | 81.0K | SEC |
| 2024-09-30 | 10-02 | Lebovits Chaim | President & CEO | P 公開市場買進 | 22.0K | 0.23 | 5K | 1.2M | SEC |
| 2024-07-19 | 07-24 | Dagher Ibrahim B. | Chief Medical Officer | S 公開市場賣出 | 63.0K | 0.35 | 22K | 0 | SEC |
| 2024-06-24 | 06-25 | HARTOUNIAN HARTOUN | EVP, Chief Operating Officer | A 獲配股票 | 30.0K | – | – | 30.0K | SEC |
| 2024-05-28 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 15.0K | 0.52 | 8K | 1.2M | SEC |
| 2024-05-28 | 06-03 | Lebovits Chaim | President & CEO | A 獲配股票 | 15.0K | 0.52 | 8K | 1.2M | SEC |
| 2024-05-22 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 25.0K | 0.64 | 16K | 1.1M | SEC |
| 2024-05-22 | 05-23 | Lebovits Chaim | President & CEO | A 獲配股票 | 25.0K | 0.64 | 16K | 1.1M | SEC |
| 2024-05-21 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 25.0K | 0.58 | 14K | 1.1M | SEC |
| 2024-05-21 | 05-23 | Lebovits Chaim | President & CEO | A 獲配股票 | 25.0K | 0.58 | 14K | 1.1M | SEC |
| 2024-05-13 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 10.0K | 0.49 | 5K | 1.1M | SEC |
| 2024-05-13 | 05-14 | Lebovits Chaim | President & CEO | A 獲配股票 | 10.0K | 0.49 | 5K | 1.1M | SEC |
| 2024-05-11 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 10.0K | 0.47 | 5K | 1.1M | SEC |
| 2024-05-11 | 05-14 | Lebovits Chaim | President & CEO | A 獲配股票 | 10.0K | 0.47 | 5K | 1.1M | SEC |
| 2024-05-10 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 20.0K | 0.47 | 9K | 1.1M | SEC |
| 2024-05-10 | 05-14 | Lebovits Chaim | President & CEO | A 獲配股票 | 20.0K | 0.47 | 9K | 1.1M | SEC |
| 2024-05-07 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 66.3K | 0.37 | 25K | 1.1M | SEC |
| 2024-05-07 | 05-07 | Lebovits Chaim | President & CEO | A 獲配股票 | 66.3K | 0.37 | 25K | 1.1M | SEC |
| 2024-05-06 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 135K | 0.38 | 51K | 994K | SEC |
| 2024-05-06 | 05-07 | Lebovits Chaim | President & CEO | A 獲配股票 | 135K | 0.38 | 51K | 994K | SEC |
| 2024-04-19 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 15.0K | 0.52 | 8K | 859K | SEC |
| 2024-04-19 | 04-25 | Lebovits Chaim | President & CEO | A 獲配股票 | 15.0K | 0.52 | 8K | 859K | SEC |
| 2024-04-18 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 115K | 0.53 | 61K | 844K | SEC |
| 2024-04-18 | 04-19 | Lebovits Chaim | President & CEO | A 獲配股票 | 115K | 0.53 | 61K | 844K | SEC |
| 2024-04-17 | 07-31 | Lebovits Chaim | President & CEO | P 公開市場買進 | 130K | 0.55 | 72K | 728K | SEC |
| 2024-04-17 | 04-19 | Lebovits Chaim | President & CEO | A 獲配股票 | 130K | 0.55 | 72K | 728K | SEC |
| 2024-03-11 | 03-13 | Lindborg Stacy | Co-Chief Executive Officer | A 獲配股票 | 242K | – | – | 423K | SEC |
| 2024-03-11 | 03-13 | Lebovits Chaim | President & CEO | A 獲配股票 | 305K | – | – | 598K | SEC |
| 2024-03-11 | 03-13 | Yablonka Uri | EVP & Chief Business Officer | A 獲配股票 | 109K | – | – | 127K | SEC |
| 2024-03-11 | 03-13 | Patlis Alla | See Remarks | A 獲配股票 | 65.2K | – | – | 65.2K | SEC |
| 2023-09-01 | 09-05 | Lindborg Stacy | Co-Chief Executive Officer | P 公開市場買進 | 11.5K | 1.77 | 20K | 182K | SEC |
| 2023-08-02 | 08-07 | Lindborg Stacy | Co-Chief Executive Officer | A 獲配股票 | 35.0K | – | – | 170K | SEC |
| 2023-08-02 | 08-04 | Lebovits Chaim | President & CEO | A 獲配股票 | 31.2K | – | – | 293K | SEC |
| 2023-06-19 | 06-21 | Naor Nir | Director | A 獲配股票 | 12.0K | – | – | 12.0K | SEC |
| 2023-05-01 | 05-01 | Taylor Kirk | Chief Medical Officer | A 獲配股票 | 35.0K | – | – | 35.0K | SEC |
| 2023-04-20 | 04-24 | Lindborg Stacy | Co-Chief Executive Officer | A 獲配股票 | 75.0K | – | – | 135K | SEC |
| 2023-04-20 | 04-24 | Lebovits Chaim | President & Co-CEO | A 獲配股票 | 75.0K | – | – | 262K | SEC |
| 2022-12-07 | 01-04 | Lindborg Stacy | Co-Chief Executive Officer | A 獲配股票 | 35.0K | – | – | 60.0K | SEC |
| 2022-09-18 | 01-04 | Lebovits Chaim | Chief Executive Officer | A 獲配股票 | 31.2K | – | – | 187K | SEC |
| 2022-03-06 | 03-14 | Kern Ralph Dr. | COO and Chief Medical Officer | A 獲配股票 | 35.9K | – | – | 223K | SEC |
| 2022-02-01 | 02-03 | Polverino Anthony J. | Director | A 獲配股票 | 3.9K | – | – | 26.0K | SEC |
| 2021-12-15 | 12-17 | TAUB MALCOLM S | Director | A 獲配股票 | 12.0K | – | – | 77.3K | SEC |
| 2021-12-15 | 12-17 | Polverino Anthony J. | Director | A 獲配股票 | 2.0K | – | – | 22.1K | SEC |
| 2021-12-15 | 12-17 | Almenoff June Sherie | Director | A 獲配股票 | 2.0K | – | – | 6.0K | SEC |
| 2021-12-10 | 12-10 | Almenoff June Sherie | Director | A 獲配股票 | 2.0K | – | – | 4.0K | SEC |
| 2021-12-10 | 12-10 | Polverino Anthony J. | Director | A 獲配股票 | 2.0K | – | – | 20.1K | SEC |
| 2021-12-10 | 12-10 | Kern Ralph Dr. | COO and Chief Medical Officer | A 獲配股票 | 35.9K | – | – | 187K | SEC |
| 2021-12-10 | 12-10 | Polverino Anthony J. | Director | A 獲配股票 | 2.2K | – | – | 18.1K | SEC |
| 2021-12-10 | 12-10 | TAUB MALCOLM S | Director | A 獲配股票 | 12.0K | – | – | 65.3K | SEC |
| 2021-12-10 | 12-10 | Abbhi Sankesh | Director | A 獲配股票 | 6.7K | – | – | 11.3K | SEC |
| 2021-12-10 | 12-10 | Lebovits Chaim | Chief Executive Officer | A 獲配股票 | 31.2K | – | – | 156K | SEC |
| 2020-12-30 | 12-31 | Shah Preetam | EVP, CFO and Treasurer | F 繳稅扣股 | 25.0K | 4.64 | 116K | 11.6K | SEC |
| 2020-09-08 | 09-10 | Waclawski Anthony | See Remarks | A 獲配股票 | 35.0K | – | – | 35.0K | SEC |
| 2020-07-26 | 07-31 | Lebovits Chaim | Chief Executive Officer | A 獲配股票 | 31.2K | – | – | 125K | SEC |
| 2020-07-16 | 07-16 | ACC International Holdings Ltd. | Other | S 公開市場賣出 | 7.8K | 13.47 | 105K | 67.1K | SEC |
| 2020-07-16 | 07-16 | Setboun David | EVP and COO | P 公開市場買進 | 5.0K | 12.95 | 65K | 55.0K | SEC |
| 2020-07-15 | 07-16 | Abbhi Sankesh | Director | P 公開市場買進 | 46.8K | 12.99 | 608K | 2.2M | SEC |
| 2020-07-15 | 07-16 | ACC International Holdings Ltd. | Other | S 公開市場賣出 | 18.4K | 13.12 | 242K | 74.9K | SEC |
| 2020-07-13 | 07-16 | ACC International Holdings Ltd. | Other | S 公開市場賣出 | 40.0K | 13.52 | 541K | 93.3K | SEC |
| 2020-07-10 | 07-16 | ACC International Holdings Ltd. | Other | S 公開市場賣出 | 2.0K | 13.35 | 27K | 133K | SEC |
| 2020-07-09 | 07-16 | ACC International Holdings Ltd. | Other | S 公開市場賣出 | 3.5K | 13.13 | 46K | 135K | SEC |
| 2020-06-23 | 06-26 | Yablonka Uri | EVP & Chief Business Officer | A 獲配股票 | 10.0K | – | – | 17.5K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2025-09-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 1.8K | 1K | 不變 | 持平 |
| Bangor Savings Bank | 266 | 188.00 | 新進 | 新進 |
| VSM Wealth Advisory, LLC | 120 | 85.00 | 新進 | 新進 |
| Steward Partners Investment Advisory, LLC | 113 | 80.00 | 新進 | 新進 |
| ST GERMAIN D J CO INC | 33 | 23.00 | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 5 +4 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 4 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 2.3K · 0.0% |
| 合計季末市值 | 2K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 49.1K |
|---|---|
| 與上期比 | +2.8% |
| 佔流通股數 | 0.44% |
| 日均成交量 | 109K |
| 回補天數 | 1.0 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 49.1K | +2.8% | 0.44% | 109K | 1.0 |
| 2026-08-14 | 47.7K | +1.5% | 0.43% | 50.1K | 1.0 |
| 2026-07-31 | 47.0K | +3.0% | 0.43% | 19.0K | 2.5 |
| 2026-07-15 | 45.7K | -22.3% | 0.41% | 106K | 1.0 |
| 2026-06-30 | 58.7K | -0.7% | 0.53% | 22.5K | 2.6 |
| 2026-06-15 | 59.2K | +9.0% | 0.54% | 30.8K | 1.9 |
| 2026-05-29 | 54.3K | +1.7% | 0.49% | 22.8K | 2.4 |
| 2026-05-15 | 53.4K | +0.1% | 0.48% | 13.2K | 4.1 |
| 2026-04-30 | 53.3K | -19.1% | 0.48% | 22.5K | 2.4 |
| 2026-04-15 | 65.9K | -30.4% | 0.60% | 20.8K | 3.2 |
| 2026-03-31 | 94.6K | -32.8% | 0.86% | 36.9K | 2.6 |
| 2026-03-13 | 141K | -48.3% | 1.28% | 51.4K | 2.7 |
| 2026-02-27 | 272K | +1.8% | 2.47% | 51.7K | 5.3 |
| 2026-02-13 | 268K | -0.3% | 2.43% | 44.8K | 6.0 |
| 2026-01-30 | 269K | +0.2% | 2.43% | 32.0K | 8.4 |
| 2026-01-15 | 268K | -0.9% | 2.43% | 33.9K | 7.9 |
| 2025-12-31 | 271K | -0.1% | 2.45% | 75.9K | 3.6 |
| 2025-12-15 | 271K | -0.8% | 2.45% | 44.5K | 6.1 |
| 2025-11-28 | 273K | -2.6% | 2.47% | 38.7K | 7.1 |
| 2025-11-14 | 280K | +1.2% | 2.54% | 27.9K | 10.0 |
| 2025-10-31 | 277K | -1.1% | 2.51% | 31.3K | 8.9 |
| 2025-10-15 | 280K | -6.7% | 2.54% | 44.5K | 6.3 |
| 2025-09-30 | 300K | -8.2% | 2.72% | 45.4K | 6.6 |
| 2025-09-15 | 327K | -4.5% | 2.96% | 39.9K | 8.2 |
| 2025-08-29 | 343K | -1.6% | 3.11% | 61.2K | 5.6 |
| 2025-08-15 | 348K | -19.3% | 3.16% | 157K | 2.2 |